Integration of Antiretroviral Therapy with Tuberculosis Treatment

In this study from South Africa, earlier initiation of antiretroviral therapy in patients with newly diagnosed HIV infection and TB was associated with higher rates of the immune reconstitution inflammatory syndrome and adverse events but increased AIDS-free survival. In patients who have infection...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine Jg. 365; H. 16; S. 1492 - 1501
Hauptverfasser: Abdool Karim, Quarraisha, Abdool Karim, Salim S, Naidoo, Kogieleum, Naidoo, Anushka, Grobler, Anneke, Padayatchi, Nesri, Baxter, Cheryl, Gray, Andrew L, Gengiah, Tanuja, Gengiah, Santhanalakshmi, Jithoo, Niraksha, Nair, Gonasagrie, El-Sadr, Wafaa M, Friedland, Gerald
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Waltham, MA Massachusetts Medical Society 20.10.2011
Schlagworte:
ISSN:0028-4793, 1533-4406, 1533-4406
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this study from South Africa, earlier initiation of antiretroviral therapy in patients with newly diagnosed HIV infection and TB was associated with higher rates of the immune reconstitution inflammatory syndrome and adverse events but increased AIDS-free survival. In patients who have infection with the human immunodeficiency virus (HIV) and tuberculosis, antiretroviral therapy (ART) may be initiated at the same time as or soon after the initiation of tuberculosis treatment. However, antiretroviral agents are often deferred until after the intensive phase of tuberculosis treatment because of concern about the immune reconstitution inflammatory syndrome (IRIS), 1 , 2 a high pill burden, and overlapping side effects 3 when three antiretroviral agents are added to the standard four antituberculosis drugs. These challenges may result in interruption or discontinuation of treatment for the acquired immunodeficiency syndrome (AIDS) or tuberculosis, which can lead to drug . . .
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMoa1014181